Erythrocyte Ca, Na/K-ATPase in long-term streptozotocin diabetic rats. Effect of good glycemic control and a Ca antagonist

Am J Hypertens. 1992 Dec;5(12 Pt 1):863-8. doi: 10.1093/ajh/5.12.863.

Abstract

This study evaluated the effect of chronic hyperglycemia on erythrocyte membrane Ca and Na/K-ATPase activities in streptozotocin-induced diabetic rats. The activity of Ca-ATPase was significantly lower in diabetic than in normal rats. Good glycemic control by insulin restored the Ca-ATPase activity to normal. By contrast, diltiazem, a calcium entry blocker, had no effect on the enzyme activity. Calmodulin stimulated Ca-ATPase activity in all groups of rats. Na/K-ATPase activity was not altered in diabetic rats, and no effects of either insulin or diltiazem treatments were observed. The results suggest that erythrocyte Ca-ATPase activity is decreased in diabetic rats and is normalized by good glycemic control.

MeSH terms

  • Animals
  • Blood Glucose / analysis*
  • Blood Glucose / drug effects
  • Blood Glucose / physiology
  • Calcium / antagonists & inhibitors*
  • Calcium-Transporting ATPases / blood*
  • Calmodulin / pharmacology
  • Diabetes Mellitus, Experimental / blood*
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / enzymology
  • Diltiazem / pharmacology
  • Diltiazem / therapeutic use*
  • Erythrocytes / enzymology*
  • Glycated Hemoglobin / analysis
  • Male
  • Rats
  • Rats, Wistar
  • Sodium-Potassium-Exchanging ATPase / blood*
  • Streptozocin
  • Time Factors

Substances

  • Blood Glucose
  • Calmodulin
  • Glycated Hemoglobin A
  • Streptozocin
  • Calcium-Transporting ATPases
  • Sodium-Potassium-Exchanging ATPase
  • Diltiazem
  • Calcium